logo
Select company
Select metric
$ -0.5EBITDA per Share
VS
Market
24
Sector
59
Industry
77
History
18
$ 3.04Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -65.55M$ -0.51130.73M
3/31/2025$ -62.6M$ -0.491128.98M
12/31/2024$ -56.34M$ -0.58197.92M
9/30/2024$ -40.1M$ -0.321126.17M
6/30/2024$ -30.4M$ -0.4175.91M
3/31/2024$ -26.39M$ -0.43160.95M
12/31/2023$ -25.61M$ -0.41161.71M
9/30/2023$ -30.8M$ -0.5161.59M
6/30/2023$ -31.47M$ -0.49164.56M
3/31/2023$ -27.17M$ -0.44161.54M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, PROKIDNEY CORP's average EBITDAPS has been $ -0.53.
  • The median EBITDAPS for PROKIDNEY CORP during this period was $ -0.46
  • PROKIDNEY CORP reached its highest EBITDAPS over the past 5 years at $ -0.11.
  • The lowest EBITDAPS recorded by PROKIDNEY CORP in the same timeframe $ -1.69

PROKIDNEY CORP's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
SEPN : SEPTERNA INC $ -1.91MREO : MEREO BIOPHARMA GROUP PLC $ -0.31ABEO : ABEONA THERAPEUTICS INC $ 1.52CRDF : CARDIFF ONCOLOGY INC $ -0.76AVTX : AVALO THERAPEUTICS INC $ -4.42BBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC $ -0.19COYA : COYA THERAPEUTICS INC $ -1.26MNMD : MIND MEDICINE (MINDMED) INC $ -1.29SANA : SANA BIOTECHNOLOGY INC $ -0.95ERNA : ERNEXA THERAPEUTICS INC $ -7.31

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for PROKIDNEY CORP is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 5M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

PROK - EBITDA per Share, Last 5 years

$ -1.69

Minimum

Dec 31, 2022

$ -0.11

Maximum

Dec 31, 2021

$ -0.53

Average

$ -0.46

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26